IT1237518B - Eparine supersolfatate - Google Patents

Eparine supersolfatate

Info

Publication number
IT1237518B
IT1237518B IT02250489A IT2250489A IT1237518B IT 1237518 B IT1237518 B IT 1237518B IT 02250489 A IT02250489 A IT 02250489A IT 2250489 A IT2250489 A IT 2250489A IT 1237518 B IT1237518 B IT 1237518B
Authority
IT
Italy
Prior art keywords
heparins
super
heparin
sulfated
sulfated heparins
Prior art date
Application number
IT02250489A
Other languages
English (en)
Other versions
IT8922504A1 (it
IT8922504A0 (it
Inventor
Renato Conti
Paolo Casati
Original Assignee
Renato Conti
Paolo Casati
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Renato Conti, Paolo Casati filed Critical Renato Conti
Publication of IT8922504A0 publication Critical patent/IT8922504A0/it
Priority to IT02250489A priority Critical patent/IT1237518B/it
Priority to PT95961A priority patent/PT95961B/pt
Priority to AT90122309T priority patent/ATE117697T1/de
Priority to DE69016383T priority patent/DE69016383T2/de
Priority to EP90122309A priority patent/EP0432537B1/en
Priority to ES90122309T priority patent/ES2068969T3/es
Priority to JP2315683A priority patent/JPH03210302A/ja
Priority to IE422590A priority patent/IE904225A1/en
Priority to US07/618,051 priority patent/US5164378A/en
Publication of IT8922504A1 publication Critical patent/IT8922504A1/it
Application granted granted Critical
Publication of IT1237518B publication Critical patent/IT1237518B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0078Degradation products
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Materials Engineering (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT02250489A 1989-11-24 1989-11-24 Eparine supersolfatate IT1237518B (it)

Priority Applications (9)

Application Number Priority Date Filing Date Title
IT02250489A IT1237518B (it) 1989-11-24 1989-11-24 Eparine supersolfatate
EP90122309A EP0432537B1 (en) 1989-11-24 1990-11-22 Supersulfated heparins
AT90122309T ATE117697T1 (de) 1989-11-24 1990-11-22 Supersulfatierte heparine.
DE69016383T DE69016383T2 (de) 1989-11-24 1990-11-22 Supersulfatierte Heparine.
PT95961A PT95961B (pt) 1989-11-24 1990-11-22 Processo para a preparacao de heparinas supersulfatadas
ES90122309T ES2068969T3 (es) 1989-11-24 1990-11-22 Heparinas supersulfatadas.
JP2315683A JPH03210302A (ja) 1989-11-24 1990-11-22 過硫酸化ヘパリン
IE422590A IE904225A1 (en) 1989-11-24 1990-11-22 Supersulfated heparins
US07/618,051 US5164378A (en) 1989-11-24 1990-11-26 Supersulfated heparins

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT02250489A IT1237518B (it) 1989-11-24 1989-11-24 Eparine supersolfatate

Publications (3)

Publication Number Publication Date
IT8922504A0 IT8922504A0 (it) 1989-11-24
IT8922504A1 IT8922504A1 (it) 1991-05-24
IT1237518B true IT1237518B (it) 1993-06-08

Family

ID=11197161

Family Applications (1)

Application Number Title Priority Date Filing Date
IT02250489A IT1237518B (it) 1989-11-24 1989-11-24 Eparine supersolfatate

Country Status (9)

Country Link
US (1) US5164378A (it)
EP (1) EP0432537B1 (it)
JP (1) JPH03210302A (it)
AT (1) ATE117697T1 (it)
DE (1) DE69016383T2 (it)
ES (1) ES2068969T3 (it)
IE (1) IE904225A1 (it)
IT (1) IT1237518B (it)
PT (1) PT95961B (it)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1244373B (it) * 1991-01-18 1994-07-08 Sclavo Spa Composizioni farmaceutiche per uso orale contenenti eparina a basso peso molecolare, loro preparazione ed uso
SE9101155D0 (sv) * 1991-04-18 1991-04-18 Kabi Pharmacia Ab Novel heparin derivatives
US5514665A (en) * 1993-12-30 1996-05-07 University Of British Columbia Method of preventing or reducing the risk of infection by bacterial pathogens utilizing simple and conjugated dextrans
US5783568A (en) * 1994-06-10 1998-07-21 Sugen, Inc. Methods for treating cancer and other cell proliferative diseases
WO1997016556A1 (en) 1995-10-30 1997-05-09 Massachusetts Institute Of Technology Rationally designed polysaccharide lyases derived from heparinase i
IT1285546B1 (it) * 1996-01-16 1998-06-18 Alfa Wassermann Spa Uso del dermatano solfato a basso peso molecolare e delle specialita' medicinali che lo contengono nella terapia e nella prevenzione della
IT1290814B1 (it) * 1997-03-24 1998-12-11 Istituto Scient Di Chimica E B Glicosaminoglicani aventi elevata attivita' antitrombotica
US7056504B1 (en) 1998-08-27 2006-06-06 Massachusetts Institute Of Technology Rationally designed heparinases derived from heparinase I and II
EP1109919A2 (en) 1998-08-27 2001-06-27 Massachusetts Institute Of Technology Rationally designed heparinases derived from heparinase i and ii
WO2000065521A2 (en) * 1999-04-23 2000-11-02 Massachusetts Institute Of Technology System and method for polymer notation
AU2001243512C1 (en) 2000-03-08 2008-04-17 Massachusetts Institute Of Technology Heparinase III and uses thereof
DK1319183T3 (da) 2000-09-12 2009-05-18 Massachusetts Inst Technology Fremgangsmåder og produkter relateret til heparin med lav molekylvægt
EP1328260A2 (en) 2000-10-18 2003-07-23 Massachusetts Institute Of Technology Methods and products related to pulmonary delivery of polysaccharides
EP1238670A1 (en) * 2001-03-07 2002-09-11 Bruce Daniels Composition and method for treating and preventing cardiovascular disease and hypertension.
JP4828795B2 (ja) 2002-03-11 2011-11-30 モメンタ ファーマシューティカルズ インコーポレイテッド 硫酸化多糖類の分析
CA2483271A1 (en) * 2002-04-25 2003-11-06 Momenta Pharmaceuticals, Inc. Methods and products for mucosal delivery
GB0306615D0 (en) * 2003-03-22 2003-04-30 Astrazeneca Ab New use
WO2007019554A2 (en) * 2005-08-08 2007-02-15 Momenta Pharmaceuticals, Inc. Polysaccharides for delivery of active agents
US9139876B1 (en) 2007-05-03 2015-09-22 Momenta Pharmacueticals, Inc. Method of analyzing a preparation of a low molecular weight heparin
US8435795B2 (en) * 2010-01-19 2013-05-07 Momenta Pharmaceuticals, Inc. Evaluating heparin preparations
WO2012115952A1 (en) 2011-02-21 2012-08-30 Momenta Pharmaceuticals, Inc. Evaluating heparin preparations
EP3398971A4 (en) * 2015-12-30 2019-09-25 Shenzhen Hepalink Pharmaceutical Group Co., Ltd. SULFATED HEPARINOLIGOSACCHARIDE AND MANUFACTURING METHOD AND APPLICATION THEREOF

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2599172A (en) * 1948-11-29 1952-06-03 Searle & Co Sulfuric acid esters of hyaluronic acid and processes for the production thereof
FR1714M (fr) * 1960-12-29 1963-02-25 Chugai Pharmaceutical Co Ltd Sulfates de polysaccharides faiblement polymérisés.
DE1418844A1 (de) * 1961-05-24 1969-05-08 Hoechst Ag Verfahren zur Herstellung von gegebenenfalls Phosphatgruppen enthaltenden Polysacchariden
US3454560A (en) * 1966-03-01 1969-07-08 Seikagaku Kogyo Co Ltd Process for the production of chondroitin polysulfate
US3506642A (en) * 1967-07-03 1970-04-14 Canada Packers Ltd Stable orally active heparinoid complexes
IT1083903B (it) * 1977-08-09 1985-05-25 Lobo Srl Oligo-eteropolisaccaridi con attivita' eparinosimili,procedimento per il loro ottenimento e relative composizioni terapeutiche
SE7811306L (sv) * 1978-11-01 1980-05-02 Rothman Gunnvor Antikoagulationsmedel samt sett for dess framstellning
JPS57134419A (en) * 1981-02-12 1982-08-19 Eisai Co Ltd Stable anticoagulant of blood
DE3244214A1 (de) * 1982-11-30 1984-05-30 B. Braun Melsungen Ag, 3508 Melsungen Verfahren zur reinigung und fraktionierung von heparin
CA1218986A (en) * 1982-12-28 1987-03-10 Annamaria Naggi Process for the depolymerisation and sulfatation of polysaccharides
US4948881A (en) * 1982-12-28 1990-08-14 Sanofi Process for the depolymerization and sulfation of polysaccharides
FR2538404B1 (it) * 1982-12-28 1985-08-23 Anic Spa
FR2548672A1 (fr) * 1983-07-04 1985-01-11 Pharmuka Lab Oligosaccharides sulfates et leur utilisation comme medicaments
JPS6049001A (ja) * 1983-08-30 1985-03-18 Eisai Co Ltd アンチトロンビン3低親和性ヘパリン
FR2584728B1 (fr) * 1985-07-12 1987-11-20 Choay Sa Procede de sulfatation de glycosaminoglycanes et de leurs fragments
FR2614026B1 (fr) * 1987-04-16 1992-04-17 Sanofi Sa Heparines de bas poids moleculaire, a structure reguliere, leur preparation et leurs applications biologiques
DE3734815A1 (de) * 1987-10-14 1989-04-27 Luitpold Werk Chem Pharm Polyschwefelsaeureester von bis-aldonsaeureamiden und deren derivaten, verfahren zu ihrer herstellung und arzneimittel
DE3744119A1 (de) * 1987-12-24 1989-07-06 Basf Ag Verwendung von polysulfatierten heparinen
WO1989012070A1 (en) * 1988-06-03 1989-12-14 Italfarmaco S.P.A. Glycosaminoglycan salts, processes for the preparation thereof and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
IE904225A1 (en) 1991-06-05
EP0432537A2 (en) 1991-06-19
JPH03210302A (ja) 1991-09-13
ATE117697T1 (de) 1995-02-15
DE69016383D1 (de) 1995-03-09
ES2068969T3 (es) 1995-05-01
PT95961A (pt) 1991-09-13
IT8922504A1 (it) 1991-05-24
PT95961B (pt) 1996-12-31
DE69016383T2 (de) 1995-07-13
IT8922504A0 (it) 1989-11-24
EP0432537B1 (en) 1995-01-25
US5164378A (en) 1992-11-17
EP0432537A3 (en) 1991-11-13

Similar Documents

Publication Publication Date Title
IT1237518B (it) Eparine supersolfatate
BE891018A (fr) Procede de purification de polymeres de sulfures d'arylene
DE69022595D1 (de) Herstellung von kohlefaser-halbfabrikaten.
FR2503714B1 (fr) Procede d'obtention de mucopolysaccharides biologiquement actifs, de purete elevee, par depolymerisation de l'heparine
FR2596765B1 (fr) Procede de preparation de polymeres acryliques de poids moleculaire eleve
RO83549A (ro) Suspensie stabila de polimerihidrosolubili si procedeu pentru obtinerea acesteia
ATE117937T1 (de) Herstellungsverfahren von zellkunststoff.
FR2618451B1 (fr) Procede et installation de vinification et utilisations s'y rapportant
FR2614047B1 (fr) Procede de greffage assurant l'impermeabilisation d'un materiau polymerique par un monomere fluore et materiau ainsi obtenu
BE873692A (fr) Procede de polymerisation de l'ethylene en plusieurs stades
NO173355C (no) Fremgangsm}te og selektiv bestemmelse av en h!ymolekylvekts hyaluronsyre og reagenssett for utf!relse av fremgangsm}ten
PT76111A (en) Process for manufacturing low molecular weight heparins by depolymerization of normal heparin
FR2558166B1 (fr) Procede de preparation d'un polymere hydrosoluble de haut poids moleculaire
ES8100364A1 (es) Un procedimiento de hilatura de filamentos de polimeros de acrilonitrilo
BR8804651A (pt) Processo para a producao de um polimero de adicao via radical livre de anidridomaleico e no minimo um 1-alceno;e polimero de adicao
FR2643371B1 (fr) Nouveaux derives de l'acide 2-amino pentanedioique, leur procede de preparation et leur application comme medicaments
FR2604625B1 (fr) Procede pour la fabrication de compositions cosmetiques a base d'acide alginique et compositions cosmetiques obtenues
ES2070364T3 (es) Mezclas polimeras homogeneas de polimeros de polimetacrilimida.
PT89491A (pt) Processo de preparacao de polimeros de organoborossilazanos
BE867526A (fr) Procede de fabrication de polymeres d'acrylonitrile ou de masses de moulage constituees par ceux-ci difficilement combustibles
ES2015100B3 (es) Proceso de produccion del acido 4,4'- dinitrostilbeno 2,2'disulfon
FR2605234B1 (fr) Procede de fabrication d'un ski et ski obtenu par ce procede
FR2521569B1 (fr) Procede de depolymerisation d'un polysaccharide possedant une structure helicoidale en batonnets
IT1230706B (it) Derivati dell'acido 3 piroglutamoil tiazolidin 4 carbossilico e loro proprieta' farmacologiche.
BE860729A (fr) Procede de preparation d'heparine et produit ainsi obtenu

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19951219